Clinical toxicity of cryopreserved circulating progenitor cells infusion

Anticancer Research

Volumn 18, Issue 6 B, 1998, Pages 4705-4708

  Zambelli, A ^a   Poggi, G ^a   Da Prada, G A ^a   Pedrazzoli, P ^a   Cuomo, A ^a   Miotti, D ^a   Perotti, C ^b   Preti, P ^a   Cuna, G Robustellidella ^a  

^a IRCCS   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Autologous PBSC transplantation; Graft infusion; Toxicity

Indexed keywords

ATROPINE; CHLORPHENIRAMINE; DIMETHYL SULFOXIDE; HYDROCORTISONE; LIQUID NITROGEN; MANNITOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABDOMINAL CRAMP; ADULT; ARTICLE; AUTOTRANSPLANTATION; BRADYCARDIA; CANCER CHEMOTHERAPY; CELL COUNT; CELL DAMAGE; CELL DEATH; CHILL; CLINICAL ARTICLE; CRYOPRESERVATION; FEMALE; FEVER; FLUSHING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINURIA; HUMAN; HUMAN CELL; HYPERTENSION; HYPOTENSION; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TACHYCARDIA; THORAX DISEASE; TOXICITY; VERTIGO; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL SURVIVAL; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; HYPERTENSION; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; TRANSPLANTATION, AUTOLOGOUS; VOMITING;

EID: 0032421834     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Armitage JO: Bone marrow transplantation. N Engl J Med 330: 827-838, 1994.
2. Gianni AM: Where do we stand with the use of peripheral blood progenitor cells? Ann Oncol 5: 781-784, 1994.
3. Gianni AM, Siena S, Bregni M, Brambilla C, Di Nicola M, Lombardi F, Gandola L, Tarella C, Pileri A, Ravagnani F, Valagussa P, Bonadonna G: High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 336: 1290-1297, 1997.
4. Siena S, Bregni M, Di Nicola M, Ravagnani F, Peccatori F, Gandola L, Lombardi F, Tarella C, Bonadonna G, Gianni AM: Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors. Ann Oncol 5: 935-941, 1994.
5. Bensinger W, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, Clarke E, Clift R, Hansen J, Shields T: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte colony-stimulating factor. Blood 81: 3158-3163, 1993.
6. Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM: Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74: 1905-1914, 1989.
7. Sheridan WP, Begley CG, Juttner CA. Szer J, To LB, Maher D, Mcgrath KM, Morstyn G, Fox RM: Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 339: 640-644, 1992.
8. Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, Horning SJ, Brown SL, Miller L Blum KG: Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81: 2031-2035, 1993.
9. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HMS, Link H, Zander A, Barge A, Borkett K: Randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347: 353-357, 1996.
10. Gratwohl A, Hermans J, Baldomero H: Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 19: 407-419, 1997.
11. Gorin N, Najman A, Salmon C, Muller JY, Petit JC, David R, Stachowiak J, Hirsh Marie F, Parlier Y, Duhamel G: High-dose combination chemotherapy with and without autologous bone marrow transplantation for treatment of acute leukemia and other malignant disease. Eur J Cancer 15: 1113-1119, 1979.
12. Davis JM, Rowley SD, Hayden G, Braine HG, Piantodosi S, Santos GW: Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 75: 781-786, 1990.
13. Smith DM, Weisenburger DD, Bierman P, Kessinger A, Vaughan WP, Armitage JO: Acute renal failure associated with autologous bone marrow transplantation. Bone Marrow Transplant 2: 195-201, 1987.
14. Styler MJ, Topolsky DL, Crilley PA, Covalesky V, Bryan R, Bulova S, Brodky I: Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant 10: 435-438, 1992.
15. Rapoport AP, Rowe JM, Packman CH, Ginsberg SJ: Cardiac arrest after autologous marrow infusion. Bone Marrow Transplant 7: 401-403, 1991.
16. Shpall EJ, LeMaistre CF, Holland K, Ball E, Jones BR, Saral R, Jacobs C, Heimfeld S, Berenson R, Champlin R: A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood 90: 4313-4320, 1997.
17. Torretta L, Perotti C, Domini G, Danova M, Locatelli F, Pedrazzoli P, Preti P, Da Prada GA, Pavesi L, Robustelli della Cuna G, Salvaneschi L:Circulating progenitor cell collection: experience from 275 leukaphereses in various malignancies and healthy donors. Haematologica 81: 208-215, 1996.
18. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AK, Lansdorp PM, Bonadonna G, Gianni AM: Row cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77: 400-409, 1991.
19. Zimmerman TM, Lee WJ, Bender JG, Mick R, Williams SF: Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant 80: 439-444, 1995.